Juno Lighting’s (JUNO) “Outperform” Rating Reaffirmed at Leerink Swann
Leerink Swann reiterated their outperform rating on shares of Juno Lighting LLC (NASDAQ:JUNO) in a research note released on Tuesday. They currently have a $45.00 target price on the biopharmaceutical company’s stock.
JUNO has been the subject of a number of other research reports. Zacks Investment Research downgraded shares of Juno Lighting from a hold rating to a sell rating in a research report on Tuesday, July 12th. Barclays PLC started coverage on shares of Juno Lighting in a research note on Wednesday, July 6th. They set an equal weight rating and a $48.00 price objective for the company. Cowen and Company reissued a buy rating and set a $55.00 price objective on shares of Juno Lighting in a research note on Sunday, July 10th. BTIG Research reissued a sell rating and set a $23.00 price objective on shares of Juno Lighting in a research note on Friday, September 9th. Finally, Vetr cut shares of Juno Lighting from a strong-buy rating to a buy rating and set a $38.02 price objective for the company. in a research note on Tuesday, August 16th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of Buy and a consensus price target of $46.27.
Juno Lighting (NASDAQ:JUNO) opened at 33.42 on Tuesday. The company has a 50 day moving average price of $31.02 and a 200 day moving average price of $36.59. The stock’s market cap is $3.40 billion. Juno Lighting has a 52 week low of $22.37 and a 52 week high of $57.82.
Juno Lighting (NASDAQ:JUNO) last announced its quarterly earnings data on Thursday, August 4th. The biopharmaceutical company reported ($0.64) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.41) by $0.23. The company had revenue of $27.60 million for the quarter, compared to analysts’ expectations of $14.26 million. The firm’s revenue for the quarter was up 121.5% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.35) EPS. Analysts expect that Juno Lighting will post ($2.48) EPS for the current fiscal year.
In other news, CEO Hans Edgar Bishop sold 84,035 shares of the business’s stock in a transaction dated Wednesday, September 21st. The shares were sold at an average price of $30.28, for a total value of $2,544,579.80. Following the completion of the sale, the chief executive officer now owns 2,518,537 shares of the company’s stock, valued at approximately $76,261,300.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Several large investors have recently added to or reduced their stakes in the company. Societe Generale bought a new stake in Juno Lighting during the second quarter valued at $153,000. SG Americas Securities LLC bought a new stake in Juno Lighting during the second quarter valued at $153,000. Metropolitan Life Insurance Co. NY increased its stake in Juno Lighting by 397.3% in the second quarter. Metropolitan Life Insurance Co. NY now owns 4,441 shares of the biopharmaceutical company’s stock valued at $171,000 after buying an additional 3,548 shares during the last quarter. Legal & General Group Plc increased its stake in Juno Lighting by 30.0% in the first quarter. Legal & General Group Plc now owns 5,164 shares of the biopharmaceutical company’s stock valued at $197,000 after buying an additional 1,192 shares during the last quarter. Finally, IFP Advisors Inc increased its stake in Juno Lighting by 103.5% in the first quarter. IFP Advisors Inc now owns 5,299 shares of the biopharmaceutical company’s stock valued at $202,000 after buying an additional 2,695 shares during the last quarter.
Juno Lighting Company Profile
Receive News & Stock Ratings for Juno Lighting LLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Juno Lighting LLC and related stocks with our FREE daily email newsletter.